SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-009820
Filing Date
2024-03-28
Accepted
2024-03-28 16:07:19
Documents
17
Period of Report
2024-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20231121_8k.htm   iXBRL 8-K 33787
2 EXHIBIT 99.1 ex_599795.htm EX-99.1 150457
3 EXHIBIT 99.2 ex_646031.htm EX-99.2 15358
8 dyadic.jpg GRAPHIC 4271
  Complete submission text file 0001437749-24-009820.txt   364674

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyai-20240326.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20240326_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20240326_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20240326_pre.xml EX-101.PRE 11584
20 EXTRACTED XBRL INSTANCE DOCUMENT dyai20231121_8k_htm.xml XML 2850
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

IRS No.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 24798881
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)